Radiation Therapy Dept., Glandore Centre, Cork University Hospital, Cork, Ireland.
Medical Imaging & Radiation Therapy, School of Medicine, University College Cork, Ireland.
Radiother Oncol. 2024 Jul;196:110286. doi: 10.1016/j.radonc.2024.110286. Epub 2024 Apr 17.
To assess osteoradionecrosis (ORN) incidence in a population of Irish Head and Neck cancer (HNC) patients, and assess precipitating factors that may contribute to ORN development to aid prevention.
Review of 1050 HNC patients attending the Dental Oncology Clinic, CUDSH between 2010 and 2021 identified 47 cases of ORN. Medical, dental and radiotherapy records of these forty-seven patients were retrospectively reviewed. Patient-, tumour-, and treatment-related variables were investigated in association with osteoradionecrosis development. Analysis conducted using SPSS, Pearson's Chi-square test (p < 0.05), and ordinal regression model.
ORN incidence was 4.4 %. Median time from radiotherapy (RT) to ORN development was 9.5 months (range 1-98.5 months). ORN development within the mandibular surgical site was significant (p <.001), presenting at a higher Notani grade (p =.002), in mid-mandibular body region (p =.028), at radiation doses ≥ 60 Gy (p =.035), due to induced causes (p =.029), and without resolution (p =.019).
This is the first retrospective study of ORN in HNC patients in Ireland over 10-year period. ORN incidence was extremely low (4.4%). As patients reported high smoking/alcohol use and poor dental attendance pre-diagnosis, this suggests intensive dental intervention pre/post-diagnosis contributed to low ORN rates. Mandibular surgery pre-RT increased risk of developing ORN at the surgical site. Therefore, we recommend future treatment planning should contour the surgical site, designating it an organ at risk (OAR), assigning a dose constraint, where oncologically possible, with emphasis on reducing the hot-spot to this region; findings reinforce importance of life-long expert dental care to reduce ORN incidence.
评估爱尔兰头颈部癌症(HNC)患者人群中的放射性骨坏死(ORN)发生率,并评估可能导致 ORN 发展的诱发因素,以助于预防。
对 2010 年至 2021 年间在 CUDSH 的牙科肿瘤诊所就诊的 1050 例 HNC 患者进行回顾性研究,发现 47 例 ORN 病例。对这 47 例患者的医疗、牙科和放射治疗记录进行了回顾性审查。研究了与放射性骨坏死发展相关的患者、肿瘤和治疗相关变量。使用 SPSS 进行分析,采用 Pearson 卡方检验(p<0.05)和有序回归模型。
ORN 发生率为 4.4%。从放疗(RT)到 ORN 发病的中位时间为 9.5 个月(范围 1-98.5 个月)。下颌骨手术部位的 ORN 发展具有显著意义(p<0.001),表现为更高的 Notani 分级(p=0.002)、下颌体中部(p=0.028)、放射剂量≥60Gy(p=0.035)、因诱导原因(p=0.029),且无缓解(p=0.019)。
这是爱尔兰 10 年来首次对头颈部癌症患者放射性骨坏死的回顾性研究。ORN 发生率极低(4.4%)。由于患者报告诊断前有大量吸烟/饮酒和不良的口腔护理习惯,这表明诊断前后的强化口腔干预有助于降低 ORN 发生率。RT 前的下颌骨手术增加了在手术部位发生 ORN 的风险。因此,我们建议未来的治疗计划应规划手术部位,将其指定为危险器官(OAR),在可能的情况下指定剂量限制,并强调减少该区域的热点;这些发现强调了终生接受专业口腔护理以降低 ORN 发生率的重要性。